Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks

The objective of this study is to analyse our experience in the treatment of refractory chronic migraine (CM) with onabotulinumtoxinA (BTA) and specifically in its effects over disabling attacks. Patients with CM and inadequate response or intolerance to oral preventatives were treated with pericran...

Descripción completa

Detalles Bibliográficos
Autores principales: Oterino, A., Ramón, C., Pascual, J.
Formato: Texto
Lenguaje:English
Publicado: Springer Milan 2011
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072485/
https://www.ncbi.nlm.nih.gov/pubmed/21298315
http://dx.doi.org/10.1007/s10194-011-0294-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072485/
https://www.ncbi.nlm.nih.gov/pubmed/21298315
http://dx.doi.org/10.1007/s10194-011-0294-8

Ejemplares similares